Calvanico N J, Garancis J C
Clin Exp Immunol. 1985 Feb;59(2):336-42.
Rabbits immunized and aerosolized with soluble protein antigens develop a short lived pulmonary inflammation. This is followed by a period of non-specific unresponsiveness which lasts approximately 30 weeks after the first exposure to aerosol treatment. This period is characterized by the inability of the rabbit to exhibit another inflammatory reaction either to the same antigen used to induce the first inflammation, or to a new antigenically unrelated antigen. After 30 weeks however, the animals become responsive (develop another pulmonary inflammation) to a second unrelated antigen, but remain unresponsive to the antigen used to elicit the initial inflammatory response. These studies indicate that following challenge with inhaled antigen, rabbits develop a non-specific suppression of pulmonary inflammation which lasts a finite period of time. When this disappears, the animal is left with an antigen specific suppression of pulmonary inflammation. These studies suggest a model for normal individuals who may respond similarly to potentially harmful inhaled allergens. Individuals with hypersensitivity pneumonitis, however, may not develop antigen specific unresponsiveness. The nature of this unresponsiveness is unknown at present, nor is it known when it begins to develop.
用可溶性蛋白质抗原免疫并雾化处理的兔子会出现短暂的肺部炎症。随后会进入一段非特异性无反应期,首次接触雾化治疗后该时期持续约30周。此时期的特征是兔子无法对用于引发首次炎症的相同抗原或新的与抗原无关的抗原表现出另一种炎症反应。然而,30周后,动物对第二种无关抗原有反应(出现另一次肺部炎症),但对用于引发初始炎症反应的抗原仍无反应。这些研究表明,吸入抗原激发后,兔子会出现持续有限时间的肺部炎症非特异性抑制。当这种抑制消失后,动物会出现抗原特异性的肺部炎症抑制。这些研究为正常个体对潜在有害吸入过敏原可能产生类似反应提出了一个模型。然而,患有过敏性肺炎的个体可能不会产生抗原特异性无反应。目前尚不清楚这种无反应的本质,也不清楚它何时开始出现。